IBEC Seminar: Aurélien Bancaud
µLAS technology for DNA processing: setting up elementary functions (concentration, separation, purification, identification) and application in oncology and targeted sequencing
Search Results for:
IBEC Seminar: Aurélien Bancaud
µLAS technology for DNA processing: setting up elementary functions (concentration, separation, purification, identification) and application in oncology and targeted sequencing
Synthetic enzymes for controlled drug delivery in cells
The Nanoscopy for Nanomedicine group has studied Single-Chain Polymeric Nanoparticles (SCPNs) mimicking enzymes as possible drug activators in biological environments, like the living cell.
The Nanoscopy for Nanomedicine group has studied Single-Chain Polymeric Nanoparticles (SCPNs) mimicking enzymes as possible drug activators in biological environments, like the living cell.The bio-inspired nanoparticles could be used to spatially control drug delivery in the treatment of diseases such as cancer.
Through their study, published in JACS, the researchers have optimized the delivery strategies of dynamic SCPNs so that they retain their catalytic activity at the cellular environment. This paves the way towards the rational design of nanosystems that can perform effective catalysis in vivo.
Postdoctoral Position in Biosensing and Bioengineering
Application Deadline: 29/03/2018
Ref: PD-JRA
The Biosensing and Bioengineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral Researcher in order to work in the project Diabetes Approach by Multi-Organ-on-a-Chip (DAMOC). This position will be funded by the “ERC Starting Grant” from the European Research Council (ERC).
IBEC PhD thesis defence: Laura Urrea
Funciones de la proteína priónica celular, a-sinucleína y Reelina en enfermedades neurodegenerativas
IBEC PhD thesis defence: Laura Urrea
Funciones de la proteína priónica celular, a-sinucleína y Reelina en enfermedades neurodegenerativas
IBEC PhD thesis defence: Laura Urrea
Funciones de la proteína priónica celular, a-sinucleína y Reelina en enfermedades neurodegenerativas
IBEC PhD thesis defence: Laura Urrea
Funciones de la proteína priónica celular, a-sinucleína y Reelina en enfermedades neurodegenerativas
Launch of SOMMa focuses on safeguarding the competitiveness of science in Spain
SOMMa, the alliance of Spain’s 25 Severo Ochoa centres – including IBEC – and 16 María de Maeztu units that aims to raise the national and international profile of science in the country, held a press launch on Monday at the Ministry of Economy, Industry and Competitiveness in Madrid.
SOMMa, the alliance of Spain’s 25 Severo Ochoa centres – including IBEC – and 16 María de Maeztu units that aims to raise the national and international profile of science in the country, held a press launch on Monday at the Ministry of Economy, Industry and Competitiveness in Madrid.At the event, the representatives of SOMMa, together with the Secretary of State for R&D&I Carmen Vela, presented the new alliance. “Joining this alliance allows us to join forces, increase our impact and encourage collaboration and networking,” said Teresa García-Milà, vice-president of SOMMa and director of the Barcelona Graduate School of Economics (BGSE). “In short, we are enriching the R&D system of this country in the long term.”
Call for Postdoctoral Candidates to apply Marie Curie for Targeted Nanotherapeutics Research Group
Application Deadline: 20/04/2018
Ref: MC-SM
The Targeted therapeutics and nanodevices group led by Prof. Muro at the Institute for Bioengineering of Catalonia (IBEC) is looking for Postdoctoral candidates to apply to the 2018 call of the European Commission Marie Curie Individual fellowship.